The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Polio (Poliomyelitis) Vaccines Market Research Report 2025
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2025.
The global Polio (Poliomyelitis) Vaccines market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 835.1 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polio (Poliomyelitis) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio (Poliomyelitis) Vaccines.
Report Scope
The Polio (Poliomyelitis) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio (Poliomyelitis) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polio (Poliomyelitis) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polio (Poliomyelitis) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polio (Poliomyelitis) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2025.
The global Polio (Poliomyelitis) Vaccines market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 835.1 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polio (Poliomyelitis) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio (Poliomyelitis) Vaccines.
Report Scope
The Polio (Poliomyelitis) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio (Poliomyelitis) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polio (Poliomyelitis) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polio (Poliomyelitis) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polio (Poliomyelitis) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Polio (Poliomyelitis) Vaccines Market Overview
1.1 Product Overview and Scope of Polio (Poliomyelitis) Vaccines
1.2 Polio (Poliomyelitis) Vaccines Segment by Type
1.2.1 Global Polio (Poliomyelitis) Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio (Poliomyelitis) Vaccines Segment by Application
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Value by Application: (2024-2030)
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Global Polio (Poliomyelitis) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Polio (Poliomyelitis) Vaccines Revenue 2019-2030
1.4.2 Global Polio (Poliomyelitis) Vaccines Sales 2019-2030
1.4.3 Global Polio (Poliomyelitis) Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Polio (Poliomyelitis) Vaccines Market Competition by Manufacturers
2.1 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Polio (Poliomyelitis) Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Polio (Poliomyelitis) Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Product Type & Application
2.7 Polio (Poliomyelitis) Vaccines Market Competitive Situation and Trends
2.7.1 Polio (Poliomyelitis) Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polio (Poliomyelitis) Vaccines Players Market Share by Revenue
2.7.3 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio (Poliomyelitis) Vaccines Retrospective Market Scenario by Region
3.1 Global Polio (Poliomyelitis) Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Polio (Poliomyelitis) Vaccines Global Polio (Poliomyelitis) Vaccines Sales by Region: 2019-2030
3.2.1 Global Polio (Poliomyelitis) Vaccines Sales by Region: 2019-2024
3.2.2 Global Polio (Poliomyelitis) Vaccines Sales by Region: 2025-2030
3.3 Global Polio (Poliomyelitis) Vaccines Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2019-2030
3.3.1 Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2019-2024
3.3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2025-2030
3.4 North America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country
3.4.1 North America Polio (Poliomyelitis) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Polio (Poliomyelitis) Vaccines Sales by Country (2019-2030)
3.4.3 North America Polio (Poliomyelitis) Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country
3.5.1 Europe Polio (Poliomyelitis) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2019-2030)
3.5.3 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Polio (Poliomyelitis) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polio (Poliomyelitis) Vaccines Sales by Type (2019-2030)
4.1.1 Global Polio (Poliomyelitis) Vaccines Sales by Type (2019-2024)
4.1.2 Global Polio (Poliomyelitis) Vaccines Sales by Type (2025-2030)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type (2019-2030)
4.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Type (2019-2024)
4.2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type (2025-2030)
4.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Polio (Poliomyelitis) Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Polio (Poliomyelitis) Vaccines Sales by Application (2019-2030)
5.1.1 Global Polio (Poliomyelitis) Vaccines Sales by Application (2019-2024)
5.1.2 Global Polio (Poliomyelitis) Vaccines Sales by Application (2025-2030)
5.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application (2019-2030)
5.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Application (2019-2024)
5.2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application (2025-2030)
5.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Polio (Poliomyelitis) Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Polio (Poliomyelitis) Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Polio (Poliomyelitis) Vaccines Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Polio (Poliomyelitis) Vaccines Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
7.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
7.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
7.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
7.4.2 Polio (Poliomyelitis) Vaccines Distributors
7.5 Polio (Poliomyelitis) Vaccines Customers
8 Polio (Poliomyelitis) Vaccines Market Dynamics
8.1 Polio (Poliomyelitis) Vaccines Industry Trends
8.2 Polio (Poliomyelitis) Vaccines Market Drivers
8.3 Polio (Poliomyelitis) Vaccines Market Challenges
8.4 Polio (Poliomyelitis) Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
